tiprankstipranks
Trending News
More News >
Psyched Wellness Ltd (PSYCF)
:PSYCF

Psyched Wellness (PSYCF) AI Stock Analysis

Compare
16 Followers

Top Page

Psyched Wellness (PSYCF) vs. SPDR S&P 500 ETF (SPY)

Psyched Wellness Business Overview & Revenue Model

Company DescriptionPsyched Wellness Ltd., a health supplements company, engages in the production and distribution of artisanal, medicinal mushrooms and associated consumer packaged goods. It offers Amanita Muscaria Tincture, which soothes the body, tackles physical distress, reduce stress, ease muscular tension, and promotes restorative sleep. The company was formerly known as Duncan Park Holdings Corporation and changed its name to Psyched Wellness Ltd. in July 2020. Psyched Wellness Ltd. was incorporated in 2019 and is based in Toronto, Canada.
How the Company Makes Money

Psyched Wellness Financial Statement Overview

Summary
Psyched Wellness shows strong revenue growth, yet it faces persistent challenges with profitability and cash flow. While the company boasts a solid equity position and no debt, negative profit margins and cash flow deficits highlight the need for strategic improvements.
Income Statement
30
Negative
Psyched Wellness has shown strong revenue growth, increasing from CAD 14,274 in 2022 to CAD 623,156 in 2024, marking a significant growth trajectory. However, the company continues to operate at a net loss with a negative net profit margin of -683% for 2024, and its EBIT and EBITDA margins are also negative, indicating ongoing challenges in achieving profitability.
Balance Sheet
45
Neutral
The balance sheet shows a solid equity position with a debt-to-equity ratio of 0, highlighting the company's reliance on equity rather than debt. However, the return on equity remains negative at -57.3%, reflecting the company's struggles with profitability. The equity ratio is robust at 94.3%, indicating financial stability.
Cash Flow
40
Negative
The company has maintained a stable cash position with significant cash reserves of CAD 6,357,977 in 2024. However, the free cash flow remains negative, and the operating cash flow to net income ratio is less than ideal, indicating ongoing cash flow challenges despite successful financing activities.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
623.16K321.10K14.27K0.000.00
Gross Profit
241.89K155.71K7.54K0.00-10.00K
EBIT
-4.52M-3.33M-3.87M-4.48M-2.15M
EBITDA
-4.52M-3.32M-4.01M-65.14K-2.06M
Net Income Common Stockholders
-4.26M-3.43M-4.73M-4.50M-2.08M
Balance SheetCash, Cash Equivalents and Short-Term Investments
6.36M6.13M2.57M5.53M2.06M
Total Assets
7.89M7.34M3.31M6.38M3.21M
Total Debt
0.000.000.000.000.00
Net Debt
-6.36M-6.13M-2.57M-5.53M-2.06M
Total Liabilities
449.33K303.56K198.07K178.15K34.85K
Stockholders Equity
7.44M7.03M3.11M6.20M3.18M
Cash FlowFree Cash Flow
-3.11M-3.11M-3.18M-3.04M-2.31M
Operating Cash Flow
-3.10M-3.03M-3.09M-3.01M-2.31M
Investing Cash Flow
-2.78K-44.84K126.99K-28.58K0.00
Financing Cash Flow
3.39M6.64M0.006.51M4.37M

Psyched Wellness Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$4.22M-68.64%
54
Neutral
$5.31B3.28-45.10%2.80%16.76%0.02%
41
Neutral
C$926.08K49.10%-6.24%81.75%
$3.73M-351.09%
C$2.24M
33
Underperform
C$1.87M-185.93%48.34%
27
Underperform
C$4.37M
-97.30%39.70%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PSYCF
Psyched Wellness
0.01
-0.05
-83.33%
TSE:MEAT
Modern Meat
0.08
-0.24
-75.00%
BABYF
Else Nutrition Holdings Inc
0.01
-0.14
-93.33%
TSE:MOOO
Happy Supplements Inc.
0.20
-0.90
-81.82%
TSE:CULT
Cult Food Science Corp.
0.02
-0.26
-92.86%
TSE:PNGA
Pangea Natural Food, Inc.
0.33
0.18
120.00%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.